Literature DB >> 23136253

Pancreatic cancer.

Caitlin C Chrystoja1, Eleftherios P Diamandis, Randall Brand, Felix Rückert, Randy Haun, Rafael Molina.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23136253     DOI： 10.1373/clinchem.2012.196642

Source DB:  PubMed          Journal:  Clin Chem        ISSN： 0009-9147            Impact factor:   8.327


× No keyword cloud information.
  11 in total

1.  N-acetyl-L-cysteine sensitizes pancreatic cancers to gemcitabine by targeting the NFκB pathway.

Authors:  Suparna Qanungo; Joachim D Uys; Yefim Manevich; Anne M Distler; Brooke Shaner; Elizabeth G Hill; John J Mieyal; John J Lemasters; Danyelle M Townsend; Anna-Liisa Nieminen
Journal:  Biomed Pharmacother       Date:  2014-08-28       Impact factor: 6.529

2.  Photodynamic Therapy Synergizes with Irinotecan to Overcome Compensatory Mechanisms and Improve Treatment Outcomes in Pancreatic Cancer.

Authors:  Huang-Chiao Huang; Srivalleesha Mallidi; Joyce Liu; Chun-Te Chiang; Zhiming Mai; Ruth Goldschmidt; Neema Ebrahim-Zadeh; Imran Rizvi; Tayyaba Hasan
Journal:  Cancer Res       Date:  2015-12-30       Impact factor: 12.701

Review 3.  MicroRNA in pancreatic cancer.

Authors:  Keiichi Yonemori; Hiroshi Kurahara; Kosei Maemura; Shoji Natsugoe
Journal:  J Hum Genet       Date:  2016-06-02       Impact factor: 3.172

4.  ZFP36L2 promotes cancer cell aggressiveness and is regulated by antitumor microRNA-375 in pancreatic ductal adenocarcinoma.

Authors:  Keiichi Yonemori; Naohiko Seki; Hiroshi Kurahara; Yusaku Osako; Tetsuya Idichi; Takayuki Arai; Keiichi Koshizuka; Yoshiaki Kita; Kosei Maemura; Shoji Natsugoe
Journal:  Cancer Sci       Date:  2017-01       Impact factor: 6.716

5.  Molecular pathogenesis of pancreatic ductal adenocarcinoma: Impact of passenger strand of pre-miR-148a on gene regulation.

Authors:  Tetsuya Idichi; Naohiko Seki; Hiroshi Kurahara; Haruhi Fukuhisa; Hiroko Toda; Masataka Shimonosono; Atsushi Okato; Takayuki Arai; Yoshiaki Kita; Yuko Mataki; Yuko Kijima; Kosei Maemura; Shoji Natsugoe
Journal:  Cancer Sci       Date:  2018-05-22       Impact factor: 6.716

6.  Involvement of anti-tumor miR-124-3p and its targets in the pathogenesis of pancreatic ductal adenocarcinoma: direct regulation of ITGA3 and ITGB1 by miR-124-3p.

Authors:  Tetsuya Idichi; Naohiko Seki; Hiroshi Kurahara; Haruhi Fukuhisa; Hiroko Toda; Masataka Shimonosono; Yasutaka Yamada; Takayuki Arai; Yoshiaki Kita; Yuko Kijima; Yuko Mataki; Kosei Maemura; Shoji Natsugoe
Journal:  Oncotarget       Date:  2018-06-22

7.  Regulation of actin-binding protein ANLN by antitumor miR-217 inhibits cancer cell aggressiveness in pancreatic ductal adenocarcinoma.

Authors:  Tetsuya Idichi; Naohiko Seki; Hiroshi Kurahara; Keiichi Yonemori; Yusaku Osako; Takayuki Arai; Atsushi Okato; Yoshiaki Kita; Takaaki Arigami; Yuko Mataki; Yuko Kijima; Kosei Maemura; Shoji Natsugoe
Journal:  Oncotarget       Date:  2017-05-29

8.  A panel of 13-miRNA signature as a potential biomarker for predicting survival in pancreatic cancer.

Authors:  Xin Zhou; Zebo Huang; Lei Xu; Mingxia Zhu; Lan Zhang; Huo Zhang; Xiaping Wang; Hai Li; Wei Zhu; Yongqian Shu; Ping Liu
Journal:  Oncotarget       Date:  2016-10-25

9.  Sulfatase-2: a prognostic biomarker and candidate therapeutic target in patients with pancreatic ductal adenocarcinoma.

Authors:  Sari F Alhasan; Beate Haugk; Laura F Ogle; Gary S Beale; Anna Long; Alastair D Burt; Dina Tiniakos; Despina Televantou; Fareeda Coxon; David R Newell; Richard Charnley; Helen L Reeves
Journal:  Br J Cancer       Date:  2016-08-25       Impact factor: 7.640

10.  Integrated analysis of circular RNA-associated ceRNA network in pancreatic ductal adenocarcinoma.

Authors:  Wei Song; Wen-Jie Wang; Tao Fu; Lei Chen; Dong-Liu Miao
Journal:  Oncol Lett       Date:  2020-01-16       Impact factor: 2.967
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.